Optiver Holding
STOK icon

Optiver Holding’s Stoke Therapeutics STOK Stock Holding History

Optiver Holding’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9K Buy
+668
New +$21.4K ﹤0.01% 1488
2026
Q1 		– Sell
-142
Closed -$4.51K – 2710
2025
Q4 		$4.51K Sell
142
-212
-60% -$6.37K ﹤0.01% 1444
2025
Q3 		$8.32K Buy
+354
New +$6.07K ﹤0.01% 1410

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Optiver Holding's STOK Position: Q2 2026 in Review

Optiver Holding opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 668 shares worth $21.9K. The stake represents ﹤0.01% of the portfolio and ranks #1488 among its holdings. This is a return to the name: Optiver Holding previously reported a position in STOK as recently as Q4 2025.

Optiver Holding first reported a position in STOK in Q3 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Optiver Holding held 668 shares of Stoke Therapeutics worth $21.9K as of Q2 2026.
  • Stoke Therapeutics was a new Optiver Holding position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1488 holding.
  • Optiver Holding first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.